Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin α4β1 by Vanderslice, Peter, Woodside, Darren G., Caivano, Amy R., Decker, E. Radford, Munsch, Christy L., Sherwood, Sidney J., LeJeune, Wanda S., Miyamoto, Yuko J., McIntyre, Bradley W., Tilton, Ronald G., Dixon, Richard A.F.

Get full text

Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist by Tilton, R G, Munsch, C L, Sherwood, S J, Chen, S J, Chen, Y F, Wu, C, Block, N, Dixon, R A, Brock, T A

Get full text

Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ETAreceptor antagonist by Tilton, Ronald G., Munsch, Christy L., Sherwood, Sidney J., Chen, Shi-Juan, Chen, Yiu-Fai, Wu, Chengda, Block, Natalie, Dixon, Richard A.F., Brock, Tommy A.

Get full text

Angiogenesis induced by tumor necrosis factor-agr; is mediated by [alpha]4 integrins by Vanderslice, Peter, Munsch, Christy L, Rachal, Eugene, Erichsen, David, Sughrue, Kay M, Truong, Ann N, Wygant, James N, Mcintyre, Bradley W, Eskin, Suzanne G, Tilton, Ronald G, Polverini, Peter J

Get full text